Clinical Trial Update: Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) [Phase 1]

View source ↗

Summary

Phase I imaging study evaluating gemcitabine/cisplatin or gemcitabine/carboplatin in participants with non-small cell lung cancer; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Carcinoma, Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2012-06-27